absci news - Search News

Needham, Absci

Hosted on MSN · 1d

Absci Corporation (ABSI): Pioneering AI-Driven Antibody Discovery with a ‘Buy’ Rating from Needham

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a look at where Absci Corporation (NASDAQ:ABSI) stands against the other medical AI stocks.

ETF Daily News · 2d

Needham & Company LLC Begins Coverage on Absci (NASDAQ:ABSI)

Equities research analysts at Needham & Company LLC assumed coverage on shares of Absci (NASDAQ:ABSI – Get Free Report) in a research report issued on Wednesday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $9.

Investing.com on MSN · 4d

Needham initiates Absci shares with Buy rating on strategy

Absci Corp. (NASDAQ:ABSI) shares, currently trading at $3.22, received a positive outlook from Needham as the firm began coverage with a Buy rating and set a price target of $9.00. The stock has shown strong momentum with a 12.

Fintel on MSN · 4d

Needham Initiates Coverage of Absci (ABSI) with Buy Recommendation

Fintel reports that on January 22, 2025, Needham initiated coverage of Absci (NasdaqGS:ABSI) with a Buy recommendation. Analyst Price Forecast Suggests 164.38% Upside As of December 23, 2024, the average one-year price target for Absci is $8.

3d

Absci shares jump as analyst lauds 'practical' AI drug company

"In our view, the ability to generate high quality wet-lab data is critical for advancement," analyst says in initiating ...

2don MSN

Cathie Wood's ARK sells Accolade stock, buys more Absci

Cathie Wood's ARK ETFs have made their daily trades public for Thursday, January 23rd, 2025, displaying a strategic shift in ...

3d

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside

Needham analyst has initiated coverage on Absci Corporation (NASDAQ:ABSI), a drug and target discovery company that harnesses ...

13d

Absci Looks Cheap And Positioned For Growth With AMD's AI Backing

Absci recently received a $20 million PIPE investment from AMD that improves its runway and R&D platform with AI. See why I ...

4d

Absci initiated with a Buy at Needham

Needham analyst Gil Blum initiated coverage of Absci (ABSI) with a Buy rating and $9 price target Absci “stands out from the pack due to its ...

6don MSN

Absci Corporation (ABSI): AI in Biopharma Discovery

We recently published a list of Complete List of All AI Companies Under $2 Billion Market Cap. In this article, we are going ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results